223 related articles for article (PubMed ID: 12966157)
21. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance.
Danysz W; Kozela E; Parsons CG; Sladek M; Bauer T; Popik P
Neuropharmacology; 2005 Mar; 48(3):360-71. PubMed ID: 15721168
[TBL] [Abstract][Full Text] [Related]
22. The NMDA antagonist MK-801 induces hyperalgesia and increases CSF excitatory amino acids in rats: reversal by guanosine.
Schmidt AP; Tort AB; Silveira PP; Böhmer AE; Hansel G; Knorr L; Schallenberger C; Dalmaz C; Elisabetsky E; Crestana RH; Lara DR; Souza DO
Pharmacol Biochem Behav; 2009 Feb; 91(4):549-53. PubMed ID: 18854198
[TBL] [Abstract][Full Text] [Related]
23. N-methyl-D-aspartate receptor antagonists potentiate the antinociceptive effects of morphine in squirrel monkeys.
Allen RM; Dykstra LA
J Pharmacol Exp Ther; 2001 Jul; 298(1):288-97. PubMed ID: 11408554
[TBL] [Abstract][Full Text] [Related]
24. Effect of N-methyl-d-aspartate receptor blockade on neuronal plasticity and gastrointestinal transit delay induced by ischemia/reperfusion in rats.
Calcina F; Barocelli E; Bertoni S; Furukawa O; Kaunitz J; Impicciatore M; Sternini C
Neuroscience; 2005; 134(1):39-49. PubMed ID: 15939544
[TBL] [Abstract][Full Text] [Related]
25. NMDA receptors of dorsal hippocampus are involved in the acquisition, but not in the expression of morphine-induced place preference.
Zarrindast MR; Lashgari R; Rezayof A; Motamedi F; Nazari-Serenjeh F
Eur J Pharmacol; 2007 Jul; 568(1-3):192-8. PubMed ID: 17509561
[TBL] [Abstract][Full Text] [Related]
26. Repeated treatment with N-methyl-d-aspartate antagonists in neonatal, but not adult, rats causes long-term deficits of radial-arm maze learning.
Kawabe K; Iwasaki T; Ichitani Y
Brain Res; 2007 Sep; 1169():77-86. PubMed ID: 17706184
[TBL] [Abstract][Full Text] [Related]
27. Effects of NMDA receptor antagonists (MK-801 and memantine) on the acquisition of morphine-induced conditioned place preference in mice.
Ribeiro Do Couto B; Aguilar MA; Manzanedo C; Rodríguez-Arias M; Miñarro J
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Sep; 28(6):1035-43. PubMed ID: 15380865
[TBL] [Abstract][Full Text] [Related]
28. The NMDA receptor antagonist MK-801 protects against the development of morphine tolerance after intrathecal administration.
Kest B; Mogil JS; Shamgar BE; Kao B; Liebeskind JC; Marek P
Proc West Pharmacol Soc; 1993; 36():307-10. PubMed ID: 8378393
[No Abstract] [Full Text] [Related]
29. Chronic nicotine and dizocilpine effects on regionally specific nicotinic and NMDA glutamate receptor binding.
Levin ED; Tizabi Y; Rezvani AH; Caldwell DP; Petro A; Getachew B
Brain Res; 2005 Apr; 1041(2):132-42. PubMed ID: 15829222
[TBL] [Abstract][Full Text] [Related]
30. The influence of NMDA receptor agonist and antagonist on morphine state-dependent memory of passive avoidance in mice.
Jafari-Sabet M; Zarrindast MR; Rezayat M; Rezayof A; Djahanguiri B
Life Sci; 2005 Nov; 78(2):157-63. PubMed ID: 16137707
[TBL] [Abstract][Full Text] [Related]
31. [Effects of Ginkgo biloba extract against excitotoxicity induced by NMDA receptors and mechanism thereof].
Xiao ZY; Sun CK; Xiao XW; Lin YZ; Li S; Ma H; Song GR; Cheng R
Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(35):2479-84. PubMed ID: 17156678
[TBL] [Abstract][Full Text] [Related]
32. Are glycineB sites involved in the development of morphine tolerance?
Kotlińska J
Pol J Pharmacol; 2004; 56(1):51-7. PubMed ID: 15047977
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of morphine analgesia by LPS: role of opioid and NMDA receptors and spinal glia.
Johnston IN; Westbrook RF
Behav Brain Res; 2005 Jan; 156(1):75-83. PubMed ID: 15474652
[TBL] [Abstract][Full Text] [Related]
34. Chronic morphine decreases calbindin D28k immunoreactivity in a subset of cerebellar Purkinje neurons of rat brain.
Garcia MM; Gilster J; Harlan RE
Brain Res; 1996 Sep; 734(1-2):123-34. PubMed ID: 8896818
[TBL] [Abstract][Full Text] [Related]
35. Effects of NMDA receptor antagonists on morphine tolerance: a c-Fos study in the lumbar spinal cord of the rat.
Le Guen S; Catheline G; Besson JM
Eur J Pharmacol; 1999 May; 373(1):1-11. PubMed ID: 10408246
[TBL] [Abstract][Full Text] [Related]
36. Developmental lead (Pb) exposure reduces the ability of the NMDA antagonist MK-801 to suppress long-term potentiation (LTP) in the rat dentate gyrus, in vivo.
Gilbert ME; Lasley SM
Neurotoxicol Teratol; 2007; 29(3):385-93. PubMed ID: 17350801
[TBL] [Abstract][Full Text] [Related]
37. MK-801 suppresses muricidal behavior but not locomotion in olfactory bulbectomized rats: involvement of NMDA receptors.
Ho YJ; Chen KH; Tai MY; Tsai YF
Pharmacol Biochem Behav; 2004 Mar; 77(3):641-6. PubMed ID: 15006477
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of NMDA receptor models of schizophrenia: divergences in the behavioral effects of sub-chronic PCP and MK-801.
Seillier A; Giuffrida A
Behav Brain Res; 2009 Dec; 204(2):410-5. PubMed ID: 19716985
[TBL] [Abstract][Full Text] [Related]
39. Purinergic P2X receptor regulates N-methyl-D-aspartate receptor expression and synaptic excitatory amino acid concentration in morphine-tolerant rats.
Tai YH; Cheng PY; Tsai RY; Chen YF; Wong CS
Anesthesiology; 2010 Nov; 113(5):1163-75. PubMed ID: 20938337
[TBL] [Abstract][Full Text] [Related]
40. Nociceptive behavior induced by poly-L-lysine and other basic compounds involves the spinal NMDA receptors.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Tadano T
Brain Res; 2004 May; 1008(1):49-53. PubMed ID: 15081381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
